Post-radiation vascular lesions of the breast.


Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 15 05 2018
revised: 03 09 2018
accepted: 19 09 2018
pubmed: 27 9 2018
medline: 13 3 2019
entrez: 26 9 2018
Statut: ppublish

Résumé

Post-radiation vascular lesions are a rare complication most commonly seen in patients previously treated for breast cancer. The main two entities include angiosarcoma (AS), which are malignant tumors that have a poor prognosis, and atypical vascular lesions (AVL), which typically behave in a benign manner and only rarely progress to angiosarcoma. The overall incidence of these lesions is low, but it appears to be increasing. Histopathologic distinction of AVL and AS is essential due to different clinical outcomes and treatment. However, due to the occasional existence of overlapping clinical and histopathologic features, it may be sometimes difficult to render a definite diagnosis, particularly in small biopsies. Ancillary techniques are, in general, of little help for separating the borderland cases but, in some instances, immunohistochemical study (IHC) for Ki67 and IHC or fluorescence in situ hybridization analysis for MYC may help in the diagnosis of angiosarcoma. Herein we discuss the clinical characteristics, histopathologic features, management strategies, and outcome of these lesions, with special emphasis on their differential diagnosis.

Identifiants

pubmed: 30251277
doi: 10.1111/cup.13363
doi:

Substances chimiques

Ki-67 Antigen 0
MKI67 protein, human 0
MYC protein, human 0
Proto-Oncogene Proteins c-myc 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-58

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Shira Ronen (S)

Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Doina Ivan (D)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Carlos A Torres-Cabala (CA)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Jonathan L Curry (JL)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Michael T Tetzlaff (MT)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Phyu P Aung (PP)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Priyadharsini Nagarajan (P)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Saul Suster (S)

Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Victor G Prieto (VG)

Department of Pathology, University of Texas-MD Anderson Cancer Center, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH